2025年7月,大约250万美国人购买了重量损失注射器,表明在获取和成本关切下需求不断增加。 In July 2025, about 2.5 million Americans bought weight-loss injectables, showing rising demand amid access and cost concerns.

据行业估计,在2025年7月,估计有250万美国人购买了可注射的减重药物,反映出尽管人们仍然对获得治疗的机会和费用感到关切,但对这种治疗的需求继续剧增。 In July 2025, an estimated 2.5 million Americans purchased weight-loss injectable medications, according to industry estimates, reflecting a continued surge in demand for these treatments despite ongoing concerns about access and cost.